149
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Thyroid Cancer Patients’ View of Clinician Professionalism and Multidisciplinary Approach to Their Management

ORCID Icon & ORCID Icon
Pages 1053-1061 | Published online: 07 May 2021

References

  • ABIM Foundation. American Board of Internal Medicine; ACP-ASIM Foundation. American College of Physicians-American Society of Internal Medicine; European Federation of Internal Medicine. Medical professionalism in the new millennium: a physician charter. Ann Intern Med. 2002;136:243–246. doi:10.7326/0003-4819-136-3-200202050-00012
  • Hojat M, Louis DZ, Markham FW, Wender R, Rabinowitz C, Gonnella JS. Physicians’ empathy and clinical outcomes for diabetic patients. Acad Med. 2011;86:359–364. doi:10.1097/ACM.0b013e3182086fe1
  • Raine R, Wallace I, Nic a’Bháird C, et al. Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study. Health Serv Delivery Res. 2014;2(37):1–72. PMID: 25642498. doi:10.3310/hsdr02370
  • Perros P, Boelaert K, Colley S, et al.; British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(Suppl 1):1–122.
  • Díez JJ, Galofré JC, Oleaga A, Grande E, Mitjavila M, Moreno P; Grupo de Trabajo de Cáncer de Tiroides de la Sociedad Española de Endocrinología y Nutrición. Consensus statement for accreditation of multidisciplinary thyroid cancer units. Endocrinol Nutr. 2016;63:e1–15. doi:10.1016/j.endonu.2015.07.005
  • Díez JJ, Galofré JC, Oleaga A, Grande E, Mitjavila M, Moreno P. Characteristics of professionalism of specialists and advantages of multidisciplinary teams in thyroid cancer: results of a national opinion survey. Endocrinol Diabetes Nutr. 2019;66:74–82. doi:10.1016/j.endinu.2018.10.009
  • Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. Br Med J. 2012;344:e2718. doi:10.1136/bmj.e2718
  • Hong NJL, Wright FC, Gagliardi AR, Paszat LF. Examining the potential relationship between multidisciplinary cancer care and patient survival: an international literature review. J Surg Oncol. 2010;102:125–134. doi:10.1002/jso.21589
  • Taylor C, Finnegan-John J, Green JS. “No decision about me without me” in the context of cancer multidisciplinary team meetings: a qualitative interview study. BMC Health Serv Res. 2014;14:488. doi:10.1186/s12913-014-0488-2
  • Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56–72. doi:10.1016/j.ctrv.2015.11.007
  • Veloski JJ, Fields SK, Boex JR, Blank LL. Measuring professionalism: a review of studies with instruments reported in the literature between 1982 and 2002. Acad Med. 2005;80:366–370. doi:10.1097/00001888-200504000-00014
  • Díez JJ, Galofré JC. Thyroid cancer patients satisfaction at the management outcome: an analysis of the results of a nationwide survey in 485 subjects. BMC Health Serv Res. 2021;21:158. doi:10.1186/s12913-021-06158-0
  • Waljee JF, Chopra V, Saint S. Mentoring millennials. JAMA. 2020;323:1716–1717. doi:10.1001/jama.2020.3085
  • Coulter A, Collins A. Making Shared Decision-Making a Reality: No Decision About Me Without Me. London: The Kings Fund; 2011.
  • O’Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;8(3):CD001431.
  • Mulley A, Trimble C, Elwyn G. Patients’ Preferences Matter, Stop the Silent Misdiagnosis. London: The Kings Fund; 2012.
  • Lamb BW, Brown KF, Nagpal K, Vincent C, Green JSA, Sevdalis N. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol. 2011;18:2116–2125. doi:10.1245/s10434-011-1675-6
  • Pieterse AH, Baas-Thijssen MCM, Marjnen CAM, Stiggelbout AM. Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer. 2008;99:875–882. doi:10.1038/sj.bjc.6604611
  • Taylor C, Ramirez AJ. Multidisciplinary team members’ views about MDT working: results from a survey commissioned by the National Cancer Action Team. National Cancer Action Team; 2009. Available from: http://www.ncin.org.uk/view.aspx?rid=137. Accessed April 30, 2021.
  • Chaillou D, Mortuaire G, Deken-Delannoy V, Rysman B, Chevalier D, Mouawad F. Presence in head and neck cancer multidisciplinary team meeting: the patient’s experience and satisfaction. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136:75–82. doi:10.1016/j.anorl.2018.10.003
  • Rabi DM, Kunneman M, Montori VM. When guidelines recommend shared decision-making. JAMA. 2020;323:1345–1346. doi:10.1001/jama.2020.1525
  • Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL. Analysis of clinical decision-making in multi-disciplinary cancer teams. Ann Oncol. 2006;17:457–460. doi:10.1093/annonc/mdj102
  • Wood JJ, Metcalfe C, Paes A, et al. An evaluation of treatment decisions at a colorectal cancer multi-disciplinary team. Colorectal Dis. 2008;8:769–772. doi:10.1111/j.1463-1318.2007.01464.x
  • Kidger J, Murdoch J, Donovan JL, Blazeby JM. Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJOG. 2009;116:511–517. doi:10.1111/j.1471-0528.2008.02066.x
  • Lanceley A, Savage J, Menon U, Jacobs I. Influences on multidisciplinary team decision-making. Int J Gynecol Cancer. 2008;18:215–222. doi:10.1111/j.1525-1438.2007.00991.x
  • Molinaro E, Campopiano MC, Pieruzzi L, et al. Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian center. J Clin Endocrinol Metab. 2020;105:dgz113.
  • Anda Apiñániz E, Zafon C, Ruiz Rey I, et al. The extent of surgery for low-risk 1–4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35. Endocrine. 2020;70:538–543. doi:10.1007/s12020-020-02371-9
  • Lamartina L, Durante C, Filetti S, Cooper DS. Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature. J Clin Endocrinol Metab. 2015;100:1748–1761. doi:10.1210/jc.2014-3882
  • Wallner LP, Reyes-Gastelum D, Hamilton AS, Ward KC, Hawley ST, Haymart MR. Patient-perceived lack of choice in receipt of radioactive iodine for treatment of differentiated thyroid cancer. J Clin Oncol. 2019;37:2152–2161. doi:10.1200/JCO.18.02228
  • Gärtner FR, Portielje JE, Langendam M, et al. Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case. BMJ Open. 2019;9:e032483. doi:10.1136/bmjopen-2019-032483